Amaia Hervas

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (9)

Josephine Elia

Division Chief, Child & Adolescent Psychiatry 2018-2023

Novartis Institutes for BioMedical Research Inc

UNITED STATES

View details

Jonas Bybjerg-Grauholm

Head of Section

Statens Serum Institut

DENMARK

View details

Lilia Iakoucheva

Professor

University of California, San Diego

UNITED STATES

View details

Kerstin Konrad

RWTH Aachen University

GERMANY

View details

Marta Ribases

SPAIN

View details

Concepció Mestres

Decana y Profesora Titular

Blanquerna Universitat Ramon Llull Facultat de Ciències de la Salut

SPAIN

View details

Maria J Arranz

Head

SPAIN

View details

MARTA HERNANDEZ

Vice-Dean for Research and Institutionals Affairs

Blanquerna Universitat Ramon Llull Facultat de Ciències de la Salut

SPAIN

View details

Guiomar Oliveira

Professor Catedrático

University of Coimbra

PORTUGAL

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amaia Hervas

Research Interests

Explore related searches

Contact this professor

Articles (10)

A Phase III Study of Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents Aged Between 7 and 17 Years with Autism Spectrum Disorder (SIGN 1 Trial): Participant Baseline Characteristics

A phenotypic spectrum of autism is attributable to the combined effects of rare variants, polygenic risk and sex

CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders

Current state of knowledge on the prevalence of neurodevelopmental disorders in childhood according to the DSM-5: a systematic review in accordance with the PRISMA criteria

Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers

Publisher Correction: A phenotypic spectrum of autism is attributable to the combined effects of rare variants, polygenic risk and sex (Nature Genetics, (2022), 10.1038/s41588-022-01064-5)

Sex differences in psychiatric comorbidity and clinical presentation in youths with conduct disorder

The methylome in females with adolescent Conduct Disorder: Neural pathomechanisms and environmental risk factors

Author Correction: Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder (Nature Communications, (2021), 12, 1, (576), 10.1038/s41467-020-20443-2)

Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)

Collaborators (9)

Josephine Elia

Jonas Bybjerg-Grauholm

Lilia Iakoucheva

Kerstin Konrad

Marta Ribases

Concepció Mestres

Maria J Arranz

MARTA HERNANDEZ

Guiomar Oliveira

Make your next move.